<DOC>
	<DOCNO>NCT00364351</DOCNO>
	<brief_summary>To determine ZD6474 new investigational drug , effective treat Non Small Lung Cancer , compare another type anti cancer therapy chemotherapy , Erlotinib</brief_summary>
	<brief_title>Efficacy Trial Comparing ZD6474 With Erlotinib NSCLC After Failure Least One Prior Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Confirmed locally advance metastatic NSCLC Failure least one two prior chemotherapy regimens Prior treatment erlotinib ( Tarceva ) , gefitinib ( IRESSA ) , sunitinib ( Sutent ) , sorafenib ( Nexavar ) Chemotherapy type anti cancer therapy within 4 week study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
</DOC>